Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy, safety, and lot-to-lot immunogenicity of an ina... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
0
Authors
Raches Ella
97 more
Raches Ella
•
Mansi Jain
95 more
•
Randeep Guleria
Published
November 11, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Immunology
Pathology
Internal Medicine
Infectious Diseases
Show all topics
DOI
10.1016/s0140-6736(21)02000-6
License
other-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Immunology
Pathology
Internal Medicine
Infectious Diseases
Show all topics
DOI
10.1016/s0140-6736(21)02000-6
License
other-oa
